Why it matters
The pharmaceuticals context.
Pharmaceutical manufacturers are committing billions to new U.S. production capacity for active ingredients, injectable medicines, biologics and other high-demand treatments. North Carolina and Indiana remain major centers of investment, while new facilities are being planned across the South. The current project pipeline includes both large greenfield campuses and major expansions of established production sites.
Project record
At a glance
- Company
- BeOne Medicines
- Industry
- Pharmaceuticals
- Location
- Hopewell Township, New Jersey
- Investment
- $300.0M
- Permanent jobs announced
- 120
- Status
- Planning
- Announced
- Jul 23, 2026
- Expected opening
- 2029
- Added to tracker
- Aug 14, 2026
Sources
Official references
- New Jersey Economic Development Authority approval https://www.njeda.gov/oncology-therapies-manufacturer-approved-for-njeda-next-new-jersey-manufacturing-award/
- Company facility context https://beonemedicines.com/about/manufacturing/hopewell-manufacturing-site/
- Hopewell Township announcement https://www.hopewelltwp.org/m/newsflash/Home/Detail/1641
- Reuters corroboration https://www.reuters.com/world/beone-announces-300-million-expansion-us-manufacturing-facility-2026-07-23/
Related
Other projects to know
Back to the tracker/projects/beone-medicines-princeton-west-small-molecule-manufacturing-expansion